StockNews.AI
INSP
StockNews.AI
140 days

Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025

1. Inspire Medical Systems will release Q1 2025 results on May 5. 2. Management will hold a conference call at 5:00 p.m. ET. 3. Replay of the call will be available two hours post-event. 4. Inspire develops FDA-approved solutions for sleep apnea treatment. 5. Company advised registering early for the conference call.

Earnings
+0.73%Current Return
VS
+0.53%S&P 500
$159.2804/01 08:07 AM EDTEvent Start
$160.44504/02 02:56 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Bullish?

Anticipation of financial results can lead to positive speculation on INSP's future performance. Historical data shows earnings beats often lead to stock price upticks.

How important is it?

The earnings report may result in noticeable stock price changes, especially if results exceed expectations.

Why Short Term?

The upcoming earnings report typically affects stock prices significantly in the short term, as investors react immediately to results and management commentary.

Related Companies

MASINUVAAXNX
April 01, 2025 08:00 ET  | Source: Inspire Medical Systems MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2025 after the close of trading on Monday, May 5. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q1 2025 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast. If you plan to ask a question, please use the following link: Inspire's Q1 2025 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.  Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks. About Inspire Medical SystemsInspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. For additional information about Inspire, please visit www.inspiresleep.com. Investor and Media ContactEzgi YagciVice President, Investor Relationsezgiyagci@inspiresleep.com 617-549-2443

Related News